FASN Inhibition Targets Multiple Drivers of Nash by Reducing Steatosis, Inflammation and Fibrosis in Preclinical Models

0
136
Researchers tested pharmacological inhibition of fatty acid synthase (FASN) in human cell culture and in three diet induced mouse models of NASH.
[Scientific Reports]
Full Article